Compare Berkshire Hathaway Inc Class B (BRK.B) vs Tempus AI (TEM) Price & Performance

BRK.B trades at $496.79, up 0.63% today, with a bullish technical outlook supported by moving averages and key support at $494. Analyst consensus is positive with 57% buy ratings, though fundamental data is currently unavailable for detailed valuation metrics. The stock shows neutral momentum oscillators but strong trend strength per ADX.

The outlook remains favorable given strong analyst support and institutional confidence, but investors face risks from macroeconomic sensitivity and execution challenges in Berkshire Hathaway's diverse portfolio. Upside is contingent on earnings growth and market stability.

Tempus AI (TEM) trades at $55.93, down 3.95% on the day, with strong analyst support (61.5% buy ratings) and a $69.20 consensus price target. The stock shows bullish technical signals with support at $55 and resistance at $58, while fundamentals reveal robust revenue growth ($1.27B in 2025) but significant losses (-$245M net income). Recent news highlights the company's expanding AI healthcare data platform and FDA approvals driving investor optimism despite ongoing profitability challenges.

TEM presents a high-risk, high-reward opportunity with Wall Street bullish on its unique healthcare data moat and AI capabilities. The primary investment thesis centers on the company's positioning to dominate precision medicine, though shareholders face substantial execution risk amid persistent losses and negative cash flow from operations. Near-term catalysts include Q2 2026 earnings on July 30 and continued expansion of high-margin data services.